Hypertensive Disorders And Cardiac Disease In Pregnancy Flashcards
(44 cards)
Hypertensive disorders during
pregnancy are classified into
Hypertensive disrders in preg are divided into 4 categories:
a) Gestational hypertension
b) Chronic hypertension
c) Chronic hypertension with superimposed preeclampsia
d) Preeclampsia-eclampsia
Hypertension in pregnancy
Hypertension in pregnancy is
defined as either:
A blood pressure of more than
140/90 mmHg on 2 occasions
more than 4-6 hours apart.
A diastolic >110 mmHg on
one occasion
A rise of more than 30 mmHg
in systolic blood pressure over
the booking pressure.
A rise of more than 15mmHg
in diastolic blood pressure
over the booking figure.
Criteria for dsis of superimposed
pre-eclampsia
(i) New onset of proteinuria >0.5
gm/24 hours specimen.
(ii) Aggravation of hypertension.
(iii) Thrombocytopenia or
(iv) Raise of liver enzymes
Common causes of chronic hypertension:
(a) Essential hypertension
(b) Chronic renal disease (reno vascular)
(c) Coarctation of aorta
(d) Endocrine disorders (diabetes mellitus, pheochromocytoma,
thyrotoxicosis
(e) Connective tissue diseases (Lupus erythematosus)
Preeclampsia
A multisystem progressive disorder of unknown etiology characterized by new onset of HTN to the extent of
140/90 mmHg or more with proteinuria after 20th wk GA in a previously normotensive & nonproteinuric woman.
New-onset HTN & end-organ dysfunction with / without proteinuria, in last 1
/2 of preg /postpartum, preeclampsia
can be diagnosed if there is evidence of 1 or more of the following abnormalities: thrombocytopenia or DIC,
elevated transaminases or other signs of hepatic injury, CNS symptoms, an elevated or rising serum
creatinine level, or pulmonary edema.
Edema is not part of diagnostic criteria unless it is pathological as eadema is common in normal preg
In hydatidiform mole and acute Polyhydramnios, preeclamptic features may appear even before 20th week
Clinical types of Preeclamsia
Types principally are based on blood pressure level and significant proteinuria
1) Mild preeclampsia: sustained rise of BP of > 140/90 mmHg but <160 mm Hg systolic or 110 mm Hg
diastolic without significant proteinuria.
PE without severe features
Diagnosed when severe disease is ruled out
2) Severe preeclapsia:
Persistent SBP of ≥160 or DBP of ≥110 mmHg.
Heavy proteinuria- of ≥ 0.3gm/24 hr urine
Oliguria (<400 ml/24 hr).
Platelet count < 100,000/mm3
HELLP syndrome Thrombocytopenia
Cerebral or visual disturbances
Persistent sev epigastric pain/ rt upper quadrant pain
Retinal hemorrhages, exudates or papilledema
Intrauterine growth restriction of the fetus
Pulmonary edema hypoxia/cyanosis
Hepatic dysfunction (elevated liver enzymes)
Risk factors for pre-eclampsia
a) Primigravida: Young or elderly (first time exposure to chorionic villi)
b) Advanced maternal age (maternal age > 35 years)
c) Family history: Hypertension, pre-eclampsia
d) Chronic Hypertension
e) Chronic renal disease
f) Placental abnormalities:
Hyperplacentosis (placenta is enlarged): Excessive exposure to chorionic villi-(molar preg, DM, hydrops)
g) Placental ischemia: results in oxidative and inflammatory stress, with involvement of secondary mediators
leading to endothelial dysfunction, vasospasm, and activation of the coagulation system.
Hypoxic placenta may also shed microparticles derived from apoptosis of syncytiotrophoblasts, which then
lead to widespread endothelial injury.
h) Diabetes (pregestational and gestational)
i) Obesity: BMI >35 kg/M2, Insulin resistance.
j) Multiple pregnancy
k) Multiparous with:
Pre-eclampsia in any previous pregnancy
Prolonged interpregnancy interval- ten years or more interval, if previous preg was normotensive
l) Pre-existing vascular disease- Pre-existing hypertension, renal diseases
m) Thrombophilias (, protein C, S deficiency, Factor V Leiden)
n) Autoimmune disorders (antiphospholipid syndrome, SLE)
o) New paternity (new partner)
p) In vitro fertilisation
q) Black race
NB: Smoking dencreases the risk of preeclampsia
Etiopathological factors for pre-eclampsia
a) Failure of trophoblast invasion (abnormal placentation)
b) Vascular endothelial damage
c) Inflammatory mediators (cytokines)
d) Immunological intolerance betwn maternal & fetal tissues
e) Coagulation abnormalities
f) Increased oxygen free radicals
g) Genetic predisposition (polygenic disorder)
h) Dietary dieficiency or excess
Pathophysiology for preeclampsia
Systemic Effect of PE
1) CVS- Marked peripheral vasoconstriction, resulting in htn
Endothelial dysfunction, increased permeability and contributes to formation of generalized oedema.
Intense vasospasm impairs circulation in vasa vasorum leading to vascular walls damage
2) Renal system- glomeruloendotheliosis (characteristic atherosclerotic-like changes in renal vessels) impairs
glomerular filtration lead to proteinuria, reduced uric excretion & oligouria (increasing serum creatinine)
3) Haematological system- Endothelial damage cause platelet aggregationthrombocytopenia, DIC, HELLP
syndrome
Third spacing of fluid (evidenced by pitting edema) is due to→
a) Hypoproteinuria ↓oncotic pressure transudation of intravascular fluid into interstitium oedema
haemoconcentration risk of hypovolemic shock if hemorrhage occurs
b) Increased blood pressure
c) Endothelial dysfunction increase permeability
4) Neurological system- Vasospasm and cerebral oedema headache, visual symptons (blurred vision, scotomas),
Hyperreflexia/hypersensitivity and convulsions (eclampsia)
Retinal haemorrhages, exudates and papilloedema are characteristic of hypertensive encephalopathy
5) Pulmonary effects: Decreased oncotic
pressure and pulmonary capillary leak and
Left heart failure → pulmonary edema
6) Liver - thrombosis of arterioles → periportal
hemorrhagic necrosis of liver starts at
periphery of the lobule
Subcapsular hemorrhage.
Subendothelial fibrin deposition is associated with elevation of liver enzymes, haemolysis and a low platelet
count due to platelet consumption
HELLP Syndrome
Acronym for Hemolysis (H), Elevated Liver enzymes (EL) and Low Platelet count (LP) (<100,000/mm3).
Rare complication of PE (10–15%). HELLP syndrome may develop even without maternal htn.
Prompt recognition is vital to improving outcomes
Manifest with nausea, vomiting, epigastric or rt upper quadrant pain, along with biochemical, & hematological changes
Parenchymal necrosis of the liver causes elevation in hepatic enzymes (AST and ALT >70 IU/L, LDH >600
IU/L) and bilirubin (>1.2 mg/dL).
There may be subcapsular hematoma formation (diagnosed by CT scanning) and abnormal peripheral bld smear.
Eventually liver may rupture to cause sudden hypotension, due to hemoperitoneum
Complications of HELLP syndrome
Maternal:
a) Abruptio placenta
b) DIC
c) Acute renal failure,
d) Severe ascites,
e) Pulmonary edema,
f) Pleural effusions,
g) Cerebral edema,
h) Laryngeal edema,
i) Retinal detachment,
j) Subcapsular liver hematoma,
k) ARDS,
l) Sepsis, and
m) Maternal mortality.
Perinatal:
a) Preterm delivery-prematurity,
b) RDS
c) Sepsis
Management of HELLP Syndrome
Antiseizure prophylaxis with magnesium sulphate
Fetal and maternal assessment before delivery
Give corticosteroid to improve perinatal (↑ pulmonary maturity, ↓ IVH and ↓NEC) and maternal (↑
thrombocyte count, ↑ urinary output) outcome
Platelet transfusion should be given if the count is <50,000/mm3
Complications of pre-eclampsia
Maternal
During pregnancy:
Eclampsia (2%)
Accidental hemorrhage, Abruptio placenta
Oliguria and anuria,
Dimness of vision and even blindness,
Preterm labor,
HELLP syndrome
Cerebral hemorrhage,
ARDS due to “leaky” pul capillaries leading to pulmonary edema
During labor:
a) Eclampsia,
b) Postpartum hemorrhage - coagulation failure
Puerperium:
a) Eclampsia - usually occurs within 48 hours,
b) Shock - puerperal vasomotor collapse is associated with reduced concentration of sodium and chloride due to
sudden fall in corticosteroid level
c) Sepsis - due to increased incidence of induction, operative interference, and low vitality
Remote
1. Residual hypertension:may persist even after 6 months following delivery in about 50% cases
2. Recurrent pre-eclampsia: in subsequent pregnancies
3. Chronic renal disease
FETAL EFFECTS: vasospasm decreases placental perfusion causing
(A) IUGR- due to chronic placental insufficiency
(B) IUFD- due to spasm of uteroplacental circulation leading to accidental hemorrhage or acute infarction,
(C) Oligohydramnios
(D) Increase perinatal mortality
(E) Increased incidence of nonreassuring fetal status in labor (results from inability of placenta to oxygenate fetus during contractions)
(a) Prematurity- either due to spontaneous preterm onset of labor or due to preter induction.
Clinical features of preeclampsia
PE is principally a syndrome of signs and when symptoms appear, it is usually late
Majority are asymptomatic
Mild symptoms:
a) Frontal headache,
b) Visual disturbance and
c) Epigastric pain or pain in rt upper quadrant
Ominous symptoms- occuring singly or in combination.
a) Headache- either occipital or frontal region
b) Disturbed sleep,
c) Diminished urinary output -Urinary output of < 400 ml in 24 hours
d) vomiting
e) Epigastric & rt abdominal pain- due to hemorrhagic gastritis or due to subcapsular hemorrhage in liver
f) Eye symptom - may be:
Blurring vision
Scotomata
Dimness of vision or at times complete blindness
Signs
a) Abnormal weight gain
b) Rise of BP
c) Edema:
d) ARDS due to Pulmonary edema
e) Abdominal examination may reveal scanty liquor or IUGR with HOF < GA due to chronic
placental insufficiency
f) Hyperreflexia and clonus (> 3 beats) in severe cases.
g) Proteinuria
h) Decreased Fundal height
NB: Course of PE appear in following order- usually insidious in onset and runs a slow course→ rapid weight
gain → visible edema and/or hypertension → proteinuria→late detection/untreated→Eclampsia
PE detected early: with effective treatment, pre-eclamptic features may subside completely
untreated preeclampsia
a) Preeclamptic features may remain stationary at varying degrees till delivery
b) Aggravation of features
c) Eclampsia- following acute fulminating PE or bypassing it
d) Rarely, spontaneous remission of preeclamptic features
Investigations for Pre-eclampsia
- Urine examination: for proteinuria, pus cells, RBCs, casts, specific gravity, M/C/S.
- FBC- Anaemia, thrombocytopenia
↓hematocrit may signify hemolysis, & ↑HCT reflects relative hypovolemia and hemoconcentration - Kidney function tests:
Serum uric acid ((biochemical marker of PE) > 6 mg % is abnormal during preg
Serum creatinine level and Blood urea level remains normal or slightly raised. - LFT and Biochem – increased liver enzymes (ALT, AST of >70 U/L), ↑bilirubin (1.2mg/dl), ↓Albumin
- Hemolysis-Abnormal PBS, ↑Indirect bilirubin level over 1.2 mg/dL, ↑LDH level > 600 U/L
- Coagulation status: Platelet count, FDP, Elevated PT or aPTT, decreased fibrinogen due to DIC.
- Ophthalmoscopic examination:
- Antenatal fetal monitoring done by
Clinical examination,
Daily fetal kick count
U/Sound for fetal growth, fetal size & liquor vol
Cardiotocography - non-stress test
Umbilical artery flow velocimetry and
Biophysical profile
Oxytocin challenge test (if needed) - CT Scanning and MRI – Reveal cerebral edema, focal infarction, intracranial hemorrhage, and posterior
leukoencephalopathy but not pathognomonic
Severe features of preeclampsia include…?
b) Proteinuria- ≥ 300mg per 24hrs urine collection, protein/creatinine ≥0.3mg/dL or urinalysis of ≥ 1+ proteinuria (if
quantitative measurements are unavailable
c) Thrombocytopenia (platelet count less than 100,000/microliter)
d) Impaired liver function- with elevated liver enzymes (transaminase) atleast twice their normal conc
e) Progressive renal insufficiency with Oliguria <500 mL in 24 hours/ creatinine conc ≥1.1mg/dL
f) New onset cerebral or visual disturbances
g) Pulmonary edema
h) Epigastric or right upper quadrant pain”
Pre-eclampsia prophylactic measures in potentially high risk women
a) Regular antenatal check up for early detection of rapid gain in weight or a tendency of rising BP.
b) Antithrombotic agents: Low dose aspirin 75 mg OD beginning early in pregnancy.
MOA: Aspirin selectively reduces platelet thromboxane production by inhibiting cyclo-oxygenase in platelets
thereby preventing the formation of thromboxane A2 without interfering with prostacyclin generation.
c) Heparin or LMW heparin is useful in those with thrombophilia and with high risk pregnancy.
d) Calcium supplementation (2 gm per day) reduces the risk of gestational hypertension.
e) Antioxidants - vits E and C and nutritional supplementation with mg, zinc, fish oil and low salt diet have been
tried but are of limited benefit.
f) Balanced diet rich in protein may reduce the risk.
Objectives of Management of pre-eclampsia
Delivery of fetus and placenta is the only definitive cure for preeclampsia
Treatment depends on
a) Severity of the disease process
b) Evidence of fetal compromise (i.e., IUGR, oligohydramnios, or heart rate abnormalities)
c) GA and fetal maturity.
Objectives are:
a) To stabilise HTN and to prevent its progression to SPE.
b) To prevent complications
c) To prevent eclampsia.
d) Delivery of a healthy baby at optimal time.
e) Mother’s health restoration in puerperium
For mild PE, without evidence of fetal compromise, and not severe or not progressing, will generally not be
delivered unless GA is ≥ 37 weeks
But for SPE or eclampsia at ≤ 34 weeks’ gestation should be delivered regardless of the GA.
There is no place of domiciliary treatment in an established case of preeclampsia
Management of pre-eclampsia
Expectant management is permitted in uncomplicated mild pre-eclampsias and pregnancy is < 34 weeks
Warn pt on ominous symptoms; headache, visual disturbances, vomiting, epigastric pain or scanty urine
Bed rest: often in left-lateral position to lessen effects of vena caval compression.
* Rest increases renal blood flow, uterine blood flow, improves placental perfusion, and reduces BP.
Diet: with adequate protein, no salt & fluid restriction
Diuretics: used judiciously as it endangers fetus by diminishing placental perfusion & electrolyte imbalance
* Only indicated in: Pulmonary edema, cardiac failure, & massive edema- refractory to rest & causing discomfort
* Commonly used is frusemide (Lasix) 40mg p.o for 5 days in a week. Preferably IV in acute conditions
Corticosteroid- Give Dexamethasone 6mg im twice 12hrs apart, to enhance lung maturity.
Antihypertensives: to control BP due to preeclampsia.
a) Methyldopa p.o is a centrally acting antihypertensive agent.
b) Labetalol p.o/iv is an α-blocking and β blocking agent.
c) Nifedipine is a Ca-channel blocker with a rapid onset of action
If pre-eclamptic features subside and hypertension is mild- but duration of preg is remote from termdischarge and review in antenatal clinic after 1 week
If < 37 wks, expectant treatment may be extended judiciously at least up to 34 weeks.
Monitoring
* Daily clinical evaluation for any symptoms (e.g. headache, epigastric pain, visual disturbances, oliguria).
* BP: at least four times a day.
* State of edema and daily wgt record.
* Fluid intake and urinary output.
* Daily urinalysis- for protein and estimate its amount in 24 hours urine.
* Bld for HCT, platelet count, uric acid, creatinine and LFT at least once a wk.
* Ophthalmoscopic examination on admission and to be repeated, PRN.
* Fetal well-being assessment-
Daily kick fetal chart,
FHR daily,
Twice weekly CTG-Non stress or biophysical profile
Serial ultrasound for growth every 2 -4 weeks, liquor vol etc.
Management for severe preeclampsia-
Counsel couple for TOP (delivery) irrespective of duration of gestation.
Definitive treatment of SPE is termination of pregnancy (delivery).
Start seizure prophylaxis (magnesium sulfate) to prevent eclampsia
Consider steroid therapy if duration of preg is < 34 weeks to prevents neonatal RDS, IVH, NEC and maternal
thrombocytopenia.
Antihypertensives – as above but doses can be titrated.
Fetal assessment
i. Daily NST
ii. Continue serial U/S for growth and fluid assessment
Indications for delivery in preeclampsia
a) Worsening fetal status: Abnormal NST, development of IUGR and Oligohydramnios
b) Worsening of maternal status
i. Uncontrolled hypertension
ii. Evidence of end-organ compromise: P/Embolism, HELLP syndrome, ↓renal function, CNS symptoms,
coagulopathy
iii. Development of HELLP syndrome
iv. Eclampsia
c) Placenta abruption
d) Attainment of a gestational age of 34 weeks
Indications for induction of labor in SPE
a) Worsening of preeclamptic features and/or appearance of newer symptoms such as epigastric pain.
b) Uncontrolled Hypertension despite of medical treatment
c) Acute fulminating pre-eclampsia irrespective of the period of gestation
Method of ILO
ILO: If cervix is ripe, surgical induction by low ROM is method of choice.
Oxytocin infusion may be added
If the cervix is unripe, PGE2 (dinoprostone) gel 500 µg intracervical or 1–2 mg posterior fornix is
inserted OR misoprotol 25mcg P.O, vaginally in the posterior fornix or rectally